NCT00197197 - Study Of Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5/X4-Tropic Treatment-Experienced HIV-Infected Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

October 31, 2005

Study Completion Date

October 31, 2005

Conditions

HIV Infection

Interventions

DRUG

GW873140

Trial Locations (12)

GSK Investigational Site, Brussels

GSK Investigational Site, Baltimore

GSK Investigational Site, Atlanta

GSK Investigational Site, Hollywood

GSK Investigational Site, Fort Lauderdale

GSK Investigational Site, Plantation

GSK Investigational Site, Chicago

GSK Investigational Site, Houston

GSK Investigational Site, Los Angeles

GSK Investigational Site, Norwalk

GSK Investigational Site, New Orleans

GSK Investigational Site, Newark